1. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Issue 10027 (9th April 2016) Authors: Lonial, Sagar; Weiss, Brendan M; Usmani, Saad Z; Singhal, Seema; Chari, Ajai; Bahlis, Nizar J; Belch, Andrew; Krishnan, Amrita; Vescio, Robert A; Mateos, Maria Victoria; Mazumder, Amitabha; Orlowski, Robert Z; Sutherland, Heather J; Bladé, Joan; Scott, Emma C; Oriol, Albert; Berdeja, Jesus; Ghari... Journal: Lancet Issue: Volume 387:Issue 10027(2016) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗